TL
DGX icon

Tradewinds LLC’s Quest Diagnostics DGX Stock Holding History

Tradewinds LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,537
Closed -$296K – 231
2026
Q1 		$296K Buy
1,537
+33
+2% +$6.41K 0.1% 108
2025
Q4 		$261K Sell
1,504
-104
-6% -$18.9K 0.06% 170
2025
Q3 		$306K Buy
+1,608
New +$285K 0.07% 162
2025
Q2 		– Sell
-1,549
Closed -$262K – 125
2025
Q1 		$262K Buy
1,549
+67
+5% +$11K 0.07% 172
2024
Q4 		$249K Sell
1,482
-48
-3% -$7.47K 0.07% 182
2024
Q3 		$238K Sell
1,530
-8
-0.5% -$1.2K 0.07% 148
2024
Q2 		$210K Sell
1,538
-2,481
-62% -$340K 0.06% 196
2024
Q1 		$547K Buy
+4,019
New +$521K 0.26% 34
2023
Q2 		– Sell
-1,574
Closed -$223K – 106
2023
Q1 		$223K Buy
+1,574
New +$225K 0.13% 111
2021
Q4 		$217K Buy
+1,571
New +$239K 0.26% 57

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Tradewinds LLC's DGX Position: Q2 2026 in Review

Tradewinds LLC sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 1,537 shares — an estimated $296K sold.

Tradewinds LLC first reported a position in DGX in Q4 2021 and held it in 10 quarters. The position peaked at $547K in Q1 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Tradewinds LLC reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Tradewinds LLC sold 1,537 Quest Diagnostics shares in Q2 2026, an estimated $296K.
  • Tradewinds LLC first reported a position in Quest Diagnostics in Q4 2021 and held it in 10 quarters.
  • Tradewinds LLC's Quest Diagnostics position peaked at $547K in Q1 2024.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.